glp-1 drugs and dementia NEW STUDY: meds slash risk by 33%. This common diabetes medication might be your best weapon yet against dementia. Dementia is affecting millions worldwide, stealing memories independence. But groundbreaking The expanding landscape of GLP-1

But covering GLP-1s for weight loss remains controversial

Co-agonism showed, on murine models, the capability to improve insulin secretion and sensitivity in a weight-dependent and weight-independent manner, probably through its action on nutrient metabolism (49, 50), preventing their accumulation and thus making these organs actively involved in metabolism with an improvement in insulin sensitivity and WL, yielding long-lasting effects

Management of diabetes mellitus with glucagonlike peptide-1 agonist liraglutide in renal transplant recipients: a retrospective study

By bypassing the GI system altogether, IV therapy can offer faster relief than oral options, helping you get back to your day more comfortably

A Note for Registered Dietitians If you are a Registered Dietitian or practitioner working with patients on GLP-1 medications, this is an area where our role is extremely important